caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1598750937

Scott AmossDPM

PodiatryWhiting, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Scott Amoss's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 27 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
COMMUNITY MEDICAL CENTER INC172516
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
146481
Bakotic Pathology Associates, Llc
Clinical Laboratory · Alpharetta, GA
85251
Accu Reference Medical Lab, Llc
Clinical Laboratory · Linden, NJ
47107
DEBORAH HEART AND LUNG CENTER4190
Maxim Karabach
Internal Medicine · Whiting, NJ
37131
Crisnoel Cervantes
Internal Medicine · Whiting, NJ
33141
Mario Gallardo
Internal Medicine · Whiting, NJ
2685
Oscar Ortiz
Endocrinology · Toms River, NJ
2253
David Grossman
Ophthalmology · Toms River, NJ
2234
Vicente Magsino
Internal Medicine · Whiting, NJ
2163
MONMOUTH MEDICAL CENTER INC1949
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
623
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
12
Brand share
5.8%
Top prescribed drugs
Terbinafine Hcl174 claims
Methylprednisolone157 claims
Cephalexin74 claims
Gabapentin61 claims
Allopurinol37 claims
QUALITY · MIPS · 2024
Final MIPS score
95.6
Quality
88.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.87%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,006
Unique beneficiaries
—
Total services
5,750
Distinct HCPCS
30
Medicare payment
$329K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 902 Podiatry providers in NJ — top quintile (cohort median 1,700).